Skip to main content
SpringerLink
Log in

Vemurafenib

Spindle cell squamous cell cancer secondary to verrucous hyperplasia: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Ziemer M, et al. Spindle cell squamous cell carcinoma arising from verrucous hyperplasia during BRAF inhibitor therapy for melanoma. Journal der Deutschen Dermatologischen Gesellschaft 13: 326-328, No. 4, Apr 2015. Available from: URL: http://doi.org/10.1111/ddg.12534 - Germany

    PubMed  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Vemurafenib. Reactions Weekly 1574, 246 (2015). https://doi.org/10.1007/s40278-015-1701-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-015-1701-8

Search

Navigation